Hongfei Wu
Tianjin University of Traditional Chinese Medicine(CN)Ministry of Education of the People's Republic of China(CN)Anhui Agricultural University(CN)Sun Yat-sen University(CN)Anhui University of Traditional Chinese Medicine(CN)Shanghai University of Traditional Chinese Medicine(CN)The First People's Hospital of Tianmen(CN)Third Affiliated Hospital of Sun Yat-sen University(CN)Chengdu University of Traditional Chinese Medicine(CN)
Publications by Year
Research Areas
Traditional Chinese Medicine Analysis, Urologic and reproductive health conditions, Urological Disorders and Treatments, Cancer-related molecular mechanisms research, MicroRNA in disease regulation
Most-Cited Works
- → miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS(2010)238 cited
- → A functional polymorphism in Pre‐miR‐146a gene is associated with prostate cancer risk and mature miR‐146a expression in vivo(2009)187 cited
- → FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy(2019)149 cited
- → A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression(2010)107 cited
- → The Anti-atherosclerotic Effect of Paeonol against Vascular Smooth Muscle Cell Proliferation by Up-regulation of Autophagy via the AMPK/mTOR Signaling Pathway(2018)84 cited
- → Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer(2017)